![Andriy Mushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andriy Mushak
Director Financiero/CFO en
TELOMIR PHARMACEUTICALS, INC.
.
Perfil
Andriy Mushak began working as Chief Financial Officer at Telomir Pharmaceuticals, Inc. in 2026 and continues in this role.
In the same year, Mr. Mushak also started as Chief Financial Officer at MIRA Pharmaceuticals, Inc. and remains in this position.
Cargos activos de Andriy Mushak
| Empresas | Cargo | Inicio |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director Financiero/CFO | 06/06/2026 |
| MIRA PHARMACEUTICALS, INC. | Director Financiero/CFO | 06/06/2026 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
1
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Bolsa de valores
- Insiders
- Andriy Mushak
Elige MarketScreener 
